share_log

Biodexa Pharmaceuticals | EFFECT: Others

SEC announcement ·  May 3 18:06
Summary by Futu AI
The United States Securities and Exchange Commission (SEC) has declared that Biodexa Pharmaceuticals Plc's submission has become effective as of May 2, 2024. The submission, identified by Accession Number 0001214659-24-007916 and File Number 333-270353, was categorized under the submission type POS AM. This notice of effectiveness by the SEC is a significant regulatory milestone for Biodexa Pharmaceuticals.
The United States Securities and Exchange Commission (SEC) has declared that Biodexa Pharmaceuticals Plc's submission has become effective as of May 2, 2024. The submission, identified by Accession Number 0001214659-24-007916 and File Number 333-270353, was categorized under the submission type POS AM. This notice of effectiveness by the SEC is a significant regulatory milestone for Biodexa Pharmaceuticals.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.